Xerion Healthcare

Xerion Healthcare

Company developing nanoparticles to improve radiotherapy cancer treatments.

All edits

Edits on 26 Mar, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 26 Mar, 2019
Edits made to:
Article (+8/-8 characters)
Article

Xerion Healthcare moved to Cherwell Innovation Centre near BicesterBicester, Oxfordshire in 2015. A £2m investment was provided by Oxford Sciences Innovation. The company has also received funding through Innovate UK’s Biomedical Early Catalyst scheme.

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 26 Mar, 2019
Edits made to:
Article (+11/-11 characters)
Article

Xerion Healthcare moved to Cherwell Innovation Centre near Bicester, OxfordshireOxfordshire in 2015. A £2m investment was provided by Oxford Sciences Innovation. The company has also received funding through Innovate UK’s Biomedical Early Catalyst scheme.

Edits on 25 Mar, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 25 Mar, 2019
Edits made to:
Article (+11/-11 characters)
Article

Xerion Healthcare moved to Cherwell Innovation Centre near Bicester, Oxfordshire in 2015. A £2m investment was provided by Oxford Sciences Innovation. The company has also received funding through Innovate UKInnovate UK’s Biomedical Early Catalyst scheme.

Meredith Hanel
Meredith Hanel edited on 25 Mar, 2019
Edits made to:
Infobox (+8 properties)
Description (+75 characters)
Article (+1077 characters)
People (+3 rows) (+6 cells) (+77 characters)
Topic thumbnail

Xerion Healthcare

Company developing nanoparticles to improve radiotherapy cancer treatments.

Article

Xerion Healthcare develops nanoparticles made from titanium dioxide which are injected into tumors prior to radiotherapy. The nanoparticles are claimed to amplify the dose of free radicals generated by X-rays, making the treatment for effective. The company is focused on head and neck and pancreatic tumors. As of 2018 the company is in pre-clinical stage.

Radiotherapy effectiveness partly relies on molecular oxygen. High energy X-ray photons generate electrons that scatter within the tumor and interact with molecular oxygen to produce superoxide radicals which damage tumor cells. Radiotherapy is less effective in areas of a tumor that are low in oxygen. Xerion Healthcare is addressing this problem with their nanoparticles which are able to generate free radicals by splitting water rather then by interacting with oxygen.

Xerion Healthcare moved to Cherwell Innovation Centre near Bicester, Oxfordshire in 2015. A £2m investment was provided by Oxford Sciences Innovation. The company has also received funding through Innovate UK’s Biomedical Early Catalyst scheme.

People

Name
Role
Related Golden topics

Dr Gareth Wakefield

CTO, Co-founder

Dr Ian George

CEO

Dr. Helen Townley

Co-founder

Infobox
Is a
Company
Industry
Medicine
Location
Oxfordshire
Date incorporated
2015
Spun Out From
University of Oxford
Country
United Kingdom
Meredith Hanel"Initial topic creation"
Meredith Hanel created this topic on 25 Mar, 2019
Edits made to:
Topic thumbnail

 Xerion Healthcare

Company developing nanoparticles to improve radiotherapy cancer treatments.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.